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The patient-physician rapport is central to medical practice 
and fundamental when evaluating quality of care at diagnosis 
and during treatment (Kayser et al., 2018). A good patient-doctor 
relationship correlates with patient satisfaction, better treatment 
compliance, and better prognosis (Mazor et al., 2018; Pedersen et 
al., 2019). Efforts have been made in recent years to develop tools 
to quantify this relationship from the patient’s perspective. 
The Patient-Doctor Relationship Questionnaire (PDRQ-9) was 
originally developed in the Netherlands as a short questionnaire 
to examine the relationship between patient and primary care 
physician from the patient’s point of view (Van der Feltz-Cornelis 
et al., 2004). The PDRQ-9 was created on the basis of the Dutch 
version of the 11-item Helping Alliance Questionnaire (HAQ) 
(Horvath et al., 1993). The PDRQ originally comprised 15 items 
and its factorial structure was evaluated by means of a principal 
 ISSN 0214 - 9915 CODEN PSOTEG
Copyright © 2021 Psicothema
www.psicothema.com
Psychometric Properties of the PDRQ-9 in Cancer Patients:
Patient-Doctor Relationship Questionnaire
Caterina Calderón1, Urbano Lorenzo-Seva2, Pere J. Ferrando2, Ruth Martínez-Cabañes3, Oliver Higuera4,
David Gómez5, María Palacin-Lois1, Vilma Pacheco-Barcia6, Raquel Hernández7, Marina Fernández-Andújar8, 
Estrella Ferreira1, Alberto Carmona-Bayonas9, and Paula Jiménez-Fonseca5
1 University of Barcelona, 2 Rovira and Virgili University, 3 Hospital Universitario Fundación Alcorcón (Madrid),
4 Hospital Universitario La Paz, 5 Hospital Universitario Central of Asturias (Oviedo), 6 Hospital Central de la Defensa “Gómez Ulla” 
(Madrid), 7 Hospital Universitario de Canarias, 8 University Abat Oliba (Barcelona), and 9 Hospital Universitario Morales
Meseguer (Murcia)
Abstract Resumen
Background: The patient-doctor relationship is an important concept 
in health care. The aim of this study was to evaluate the psychometric 
properties, convergent validity, and factorial invariance of the Patient-
Doctor Relationship Questionnaire (PDRQ-9). Method: Confi rmatory 
factor analysis was conducted to explore the scale’s dimensionality and 
test for strong measurement invariance across sex, age, and tumor site 
in a prospective, multicenter cohort of 560 patients who completed the 
PDRQ-9, Health-related Quality of Life Questionnaire (EORTC-QLQ-
C30), and Brief Symptom Inventory (BSI) scales. Results: The data 
supported a unidimensional structure. Thresholds and factor loadings 
could be constrained to be invariant across sex, age, and tumor site, 
indicating strong measurement invariance. Scores derived from the 
unidimensional structure exhibited satisfactory degrees of reliability and 
determinacy. Evidence of convergent validity was supported by modest 
positive correlations with functional (p<.001) and global quality-of-life 
(p<.001) and negative correlations with psychological distress (p<.001). 
Low satisfaction with the oncologist was associated with anxiety (p=.006), 
and depression (p=.004). Conclusions: The PDRQ-9 is a suitable, valid 
instrument for assessing the quality of patient-doctor relationships in 
cancer patients.
Keywords: Invariance; factor analysis; patient-reported outcome measures; 
oncology; validity.
Propiedades Psicométricas del PDRQ-9 en Pacientes con Cáncer: 
Cuestionario de Relación Médico-Paciente. Antecedentes: la relación 
médico-paciente es un concepto importante en cuidado de la salud. El 
objetivo de este estudio fue evaluar las propiedades psicométricas, la 
validez y la invariancia factorial del Cuestionario de Relación Médico-
Paciente (PDRQ-9). Método: se realizó un análisis factorial confi rmatorio 
para explorar la dimensionalidad de la escala y la invariancia de 
medición a través del sexo, la edad y la localización del tumor en una 
cohorte prospectiva multicéntrico de 560 pacientes que completaron el 
PDRQ-9, el Cuestionario de Calidad de Vida (EORTC-QLQ-C30) y la 
Inventario Breve de Síntomas (BSI-18). Resultados: los datos apoyaron 
una estructura unidimensional. Los umbrales y las cargas de los factores 
podían considerarse invariantes en función del sexo, la edad y localización 
de tumor (invariancia fuerte). Las puntuaciones derivadas de la estructura 
unidimensional mostraron grados satisfactorios de confi abilidad y 
determinación. La evidencia de validez convergente fue apoyada por 
correlaciones positivas modestas con la escala funcional (p<.001) y la 
calidad de vida (p<.001) y correlaciones negativas con malestar psicológico 
(p<.001). La baja satisfacción con el oncólogo estuvo asociada a mayor 
ansiedad (p =.006) y depresión (p= .004). Conclusiones: el PDRQ-9 es 
un instrumento válido y adecuado para evaluar la calidad en la relación 
médico-paciente en pacientes con cáncer.
Palabras clave: invariancia; análisis factorial; medidas de resultado 
informadas por el paciente; invariancia; oncología; validez.
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components analysis (PCA) in a sample of 110 general practice 
patients and 55 patients in a Epilepsy Clinic (Van der Feltz-
Cornelis et al., 2004). The factorial analysis of the scale indicated 
two factors; the fi rst one with good internal consistency probed 
the physician’s empathic, approachable style, while the second, 
with moderate consistency, integrated the patient’s medical 
symptoms. With the aim of creating a patient-doctor relationship 
rating scale, the second-factor items were eliminated, and the 
fi nal, unidimensional 9-item PDRQ-9 scale was developed. This 
questionnaire collects aspects such as communication, satisfaction 
with the treatment and accessibility to the doctor. 
The PDRQ-9 has been translated to and validated in Spanish 
(Martín-Fernández et al., 2010; Mingote et al., 2009), Portuguese 
(Wollmann et al., 2018), German (Zenger et al., 2014), Turkish 
(Mergen et al., 2012), and Bengali (Arafat, 2016). Scale scores show 
excellent internal-consistency reliability (Cronbach’s alpha of .94), 
satisfactory test-retest reliability, and adequate validity relations 
in the context of Primary Care. However, as suggested (Van der 
Feltz-Cornelis et al., 2004), studies with other patient populations 
are needed to confi rm these fi ndings. In this regard, the PDRQ-9 
has been used with a sample of individuals with schizophrenia 
(Aloba et al., 2015) and in patients with mental disorders (Arafat, 
2016), endorsing the scale’s psychometric properties.   
Another relevant aspect of the PDQR-9’s factor structure is the 
study of intergroup measurement invariance (e.g., gender, age, 
or tumor site). Testing the measurement invariance hypothesis 
enables comparisons to be made across groups, yielding easily 
interpretable results, as opposed to scenarios in which this premise 
is not examined. So far as we know, the psychometric properties 
of the PDRQ-9 and the invariance study have not been analyzed in 
a sample of oncology patients. Therefore, the aim of this study is 
to analyze the PDRQ-9’s factor structure, convergent validity, and 




The study included 560 patients with cancer, predominantly 
female (58.4%), aged 26-85 years (M=58.9, SD=12.0), married or 
partnered (79.8%), and inactive (60.4%). Most of the participants 
had colorectal (44.3%) or breast (34.3%) cancer, stage I-II (54.1%), 
and all received adjuvant chemotherapy; 31.6% also received 
radiotherapy. Men were more satisfi ed with their physician than 
women (F 
(1,559)
=6.39; p=.012; η2=.011), as well as patients who 
were married or partnered versus unmarried, widowed, or divorced 
(F 
(1,599)=
4.60; p=.032; η2 =.008) (see Table 1). 
Instruments
Patient-Doctor Relationship Questionnaire (PDRQ-9) (Van der 
Feltz-Cornelis et al., 2004) is a 9-item scale that assesses patients’ 
perception of the relationship with the physician (in the context 
of this study, the oncologist); thus, it serves as a brief measure 
to quantify the therapeutic dimensions of the patient-doctor 
relationship. Items are scored on a 5-point Likert scale ranging from 
‘not at all appropriate’ to ‘totally appropriate’. Raw sum scores 
range from 9 to 45, with higher scores indicating that the patient’s 
perception of the patient-doctor relationship is more favorable. 
Participants completed the PDRQ-9 without the presence of the 
oncologist under which they were registered for treatment. This 
was done to encourage patients to provide their honest opinion. 
The internal consistency reliability estimates for sum scores based 
on the scale’s nine items for this study was high (α=.97).
European Organization for Research and Treatment of Cancer 
Quality of Life Questionnaire (EORTC QLQ-C30) is used 
extensively in Europe to assess quality of life and its validity has 
been well established (Aaronson et al., 1993). The 30 items comprise 
three subscales: ‘Functioning,’ ‘Symptom,’ ‘Global QoL’. Score 
categories range from 1 (not at all) to 4 (very much), except for 
the global QoL scale, where item scores range from 1 (very poor) 
to 7 (excellent). All sum-scale scores are linearly transformed into 
a 0-100 scale. For the functioning scales and the global QoL scale; 
higher scores represent higher levels of functioning or QoL. For the 
symptom scales, higher scores represent more symptom burden.
Brief Symptom Inventory (BSI) was used to evaluate anxiety 
and depression. It includes 12 symptoms to assess the degree of 
anxiety and depression on a fi ve-point scale ranging from ‘total 
absence of symptom‘ (1) to ‘full presence of symptom‘ (5) 
(Derogatis, 2001). Cronbach’s alpha estimates ranged from .75 to 
.88 (Calderón et al., 2020).
Table 1
 Association between PDRQ-9 and socio-demographic and clinical 
characteristics of the sample
Characteristics n % M SD F P
Gender 6.39 .012
Male 233 41.6 42.6 4.5
Female 327 58.4 41.5 5.3
Marital status 4.60 .032
Married or partnered 447 79.8 42.2 4.9
Single/widowed, divorced 113 20.2 41.1 5.6
Educational level 1.77 .183
Primary 312 55.7 42.2 4.4
High school or above 248 44.3 41.6 5.7
Age group (years) 1.09 .337
≤ 55 203 36.3 41.6 5.4
56-65 173 30.9 42.3 4.6
≥ 66 184 32.9 42.2 5.0
Employment status 1.54 .214
Inactive 338 60.4 42.2 4.8
Active 222 39.6 41.6 5.4
Tumor site 2.43 .089
Colon 248 44.3 42.5 4.4
Breast 192 34.3 41.7 5.1
Others 120 21.4 41.4 6.0
Tumor stage (15 missing values) 2.52 .081
I-II 303 54.1 41.6 5.2
III 242 43.2 42.5 4.3
Tumor treatment 2.73 .099
Chemotherapy 383 68.4 42.2 4.9
Chemo- & radiotherapy 177 31.3 41.4 5.3
Note: Bold values indicate signifi cance at the 5% level
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Demographic and clinical variables. Age, gender, marital status 
(married/partnered, not partnered), fi ve age group (≤55, 56-65, 
≥66 years), employment status (inactive, active), tumor site (colon, 
breast, others), cancer treatment (chemotherapy, chemotherapy 
and radiotherapy) and tumor stage (I-II, III). 
Procedure
Five hundred and seventy-fi ve patients were recruited 
consecutively at 15 tertiary referral hospitals in Spain. Adults 
>18 years old (1) with a pathologic diagnosis of cancer of any 
type (2) with nonmetastatic, resected cancer eligible for adjuvant 
chemotherapy (3). All participants were informed of study 
procedures, data collection, and anonymization of all personal 
data. Written informed consent was obtained from all patients 
prior to study commencement, and the protocol was approved by 
the Ethics Review Board at each institution and by the Spanish 
Agency of Medicines and Medical Devices (AEMPS). STROBE 
guidelines were used to ensure reporting of this study (von Elm et 
al., 2008). The questionnaire was administered six months after 
initiating chemotherapy. Of the 673 patients screened, 113 were 
not eligible (23 did not meet inclusion criteria; 29 met exclusion 
criteria, and 61 had incomplete data).  
Data analysis 
Preliminary data analyses were conducted using SPSS software 
Version 23.0 (SPSS, Inc. Chicago, IL). Descriptive statistics were 
calculated for demographic and clinical characteristics. One-
way analysis of variance (ANOVAs) were conducted to gauge 
variations in PDRQ-9 with respect to sociodemographic and 
clinical variables.
Confi rmatory factor analyses (CFAs) were performed in two 
steps. In the preliminary step, the unidimensional FA model 
assumed for the PDQR-9 items was fi tted to the entire sample 
of participants In the second step, measurement invariance was 
appraised in groups defi ned by gender, age, and tumor site. All 
factor analysis (FA) models were fi tted using robust weighted 
least squares estimation with second order (mean and variance) 
corrections as implemented in Mplus (see Muthén, 2007). Model fi t 
and appropriateness were evaluated with three types of measures. 
Model residuals and relative fi t (fi rst type) were assessed with 
SRMS and RMSEA statistics. Comparative fi t (second type) was 
examined using the CFI index (as a relative measure of fi t with 
respect to the null independence model). Finally, the third type 
(see Calderón et al., 2019) was performed in the overall analysis 
and included additional indices of appropriateness for evaluating 
the strength and replicability of the solution (H index), as well as 
closeness to unidimensionality (ECV index). These indices were 
obtained by using the Factor Program (Ferrando & Lorenzo-Seva, 
2013, 2019). As for reference values, CFI values ≥.95 are indicative 
of good model fi t (Schermelleh-Engel et al., 2003), whereas SRMR 
values ≤.08 and RMSEA values ≤.06 are considered satisfactory 
fi tting models (Hair et al., 2010; Schermelleh-Engel et al., 2014). 
The purposes for which the PDQR-9 is intended include 
validly interpreting individual and mean group comparisons. More 
specifi cally, scores of individuals belonging to different groups 
(e.g., male vs. female) need to be comparable and mean intergroup 
differences, validly interpreted. These requirements determined 
the degree of invariance that was assessed in the multiple-group 
analyses. Strong or scalar invariance (Millsap & Meredith, 2007) 
suffi ces to meet the afore-named requirements (see Ferrando, 1996), 
and was deemed a reasonable aim for the PDRQ-9 items. Stricter 
forms of invariance are not only unnecessary for our purposes, but 
can lead to biased parameter estimates when forced in a solution 
(see Little, 1997). So, strong invariance will be evaluated in the 
multiple-group CFAs, and, if attained, mean differences in groups 
defi ned by gender, age, and tumor site will then be examined.
The appropriateness and accuracy of the PDQR-9 scores was 
ascertained in several ways. First, the reliability and determinacy 
of the factor score estimates was established by the factor 
determinacy index (FDI) and marginal reliability estimate of 
these scores. Second, reliability of the simpler sum scale scores 
as proxies for factor scores was verifi ed using McDonald’s omega 
estimate. Thirdly, the relations between the factor score estimates 
and the sum scores was further assessed graphically. Finally, the 
local accuracy at different trait levels was assessed using the 
conditional reliability estimates.
Lastly, evidence of convergent validity was explored in two 
ways. First, product-moment correlations were obtained between 
PDQR-9 raw scores and four of the EORTC indices (functional scale, 
symptom scale, overall health, and QoL), as well as the anxiety and 
depression scores from the BSI. Second, a structural equation model 
was fi tted to the data, in which the CFA was extended to include 
the external scores above. The fi rst type of validity coeffi cients 
is empirical, with no error corrections. The standardized validity 
coeffi cients estimated from the structural model are disattenuated 
and correct the PDQR-9 scores for measurement error.
Results
Descriptive statistics for PDRQ-9 items
Table 2 presents the descriptive statistics of the PDRQ-9. The 
mean satisfaction index was 42.0 (SD=5.1); half of the participants 
Table 2
Characteristics of PDRQ-9 items
Items M SD Skewness rit
α if item 
deleted
My oncologist helps me1. 4.6 .51 -2.61 .84 .94
 My oncologist physician has 2. 
enough time for me
4.5 .70 -1.92 .70 .95
I trust my oncologist.3. 4.7 .36 -3.36 .82 .94
My oncologist understands me4. 4.6 .50 -2.43 .81 .94
 My oncologist is dedicated to 5. 
helping me
4.9 .44 -2.67 .88 .94
 My oncologist and I agree about the 6. 
nature of my medical symptoms
4.6 .48 -2.58 .83 .94
I can talk to my oncologist7. 4.7 .40 -3.16 .79 .95
 I feel content with my 8. 
oncologist’s treatment
4.7 .41 -3.23 .80 .94
 I fi nd my oncologist easily 9. 
accessible
4.6 .55 -2.54 .80 .94
PDRQ-9 total 42.0 4.66
Note: r
it
 = Item Discrimination Index 
Psychometric Properties of the PDRQ-9 in Cancer Patients: Patient-Doctor Relationship Questionnaire
307
expressed the maximum satisfaction possible. This result could 
be anticipated by inspecting the distribution, and particularly 
the skewness of the PDRQ-9 items: unimodal and asymmetrical 
left skewed distribution, indicating that most of the values were 
concentrated to the right of the mean. Corrected item-total 
correlations (item discrimination indices) were all >.70, showing 
that all items accounted for a substantial amount of the variance of 
the total scale. 
Confi rmatory factor analysis and measurement invariance 
Given that the item scores were ordered-categorical, with 
strongly negative skewed distributions and the sample size was 
large, we decided that the most suitable factor-analysis procedure 
was the non-linear item factor analysis model based on an 
underlying-variables approach, which proved to be feasible for all 
the analyses that follow. In this model, the item scores are treated 
as ordered-categorical variables and the FA solution is fi tted to 
the inter-item polychoric correlation matrix (see Ferrando & 
Lorenzo-Seva, 2013, for further details). As mentioned above, the 
fi tting function was robust unweighted leas squares, with mean-
and-variance corrected fi t statistics (Ferrando & Lorenzo-Seva, 
2018). 
Preliminary inspection of the thresholds under the ordered-
categorical chosen FA model, showed that, even with the stronger 
skews, no zero frequencies existed in any of the categories and the 
item thresholds were fi nite and increasing. As for the structural 
results, those at the overall sample level suggested that the 
unidimensional FA model fi tted the data quite well and the values 
of the standard indices displayed good fi t in all cases: SRMS=.02; 
RMSEA=.05, and CFI=.99. Furthermore, the H value vas .98, 
signifying that the factor was well defi ned by the 9 items and that 
the solution was strong and replicable. Finally, the ECV value 
was .98, indicating that 98% of the common variance of the item 
scores could be explained by the fi tted single factor. So, clearly, the 
solution can be considered as essentially unidimensional (Calderón 
et al., 2019). As for the structural estimates, standardized factor 
loadings for the 9 items can be found in Figure 1. All are noticeably 
high, which attests to excellent internal consistency and low 
measurement error, albeit, possibly, some redundancy in content. 
As for invariance, strong measurement invariance was attained 
for the three grouping variables contemplated here. In all cases 
the strong models’ fi t was better in relative terms than that of the 
previous baseline and weak invariance models; thus, only strong 
invariance results are shown in Table 3, together with mean 
group estimates. To interpret these results, the reader must take 
into account that the mean of the fi rst group is fi xed to zero for 
identifi cation purposes and that the remaining means are to be 
compared with this fi xed value in terms of their standard errors.
Results can be summarized as follows. In terms of gender, 
women reveal statistically signifi cantly low levels of satisfaction 
with their relationship with the physician, as the fi xed zero value 
in the men group falls outside the 95% confi dence interval around 
the mean for women. The effect size for this difference (Cohen’s 
d) is approximately .50, which would qualify as medium. In terms 
of tumor site, no signifi cant differences between group means 
emerge. Finally, levels appear to increase with age. Nevertheless, 
the difference between the oldest and the youngest group fails to 
achieve statistical signifi cance.
Measurement accuracy
The marginal reliability of the factor scores estimates based on 
the unidimensional factor-analytic solution exceeded .98 and the 
FDI value was .99. McDonald’s omega reliability estimate based 
on the simple sum scores was .98, while the alpha estimate was 
.97. Taken together, these results can be interpreted as follows 
(see Ferrando & Lorenzo-Seva, 2018). Factor score estimates 
derived from the solution in Figure 1 are highly accurate and 
comprise univocal indicators of the factor they intend to measure 
(the favorableness of the perceived patient-doctor relationship). 
Furthermore, reliability of the simpler sum scores approaches that 
of the factor score estimates, suggesting that sum scores can be 
used as proxies for factor score estimates with minimal loss of 
accuracy.
Figure 2 displays the regression of the sum scores on the factor 
score estimates and illustrates the strong relation and almost virtual 
Figure 1. Unidimensional Factorial Analysis model with standardized 
loading
Table 3
Strong invariance results for gender, age, and tumor site
Groups Mean SE χ 2 (df) CFI RMSEA (90% CI)
Gender 114.83 (88) .99 .03 (.01-.04)
Men (fi xed) .00
Women -.38 .13
Age group (years)
Group 1 (≤ 55) (fi xed) .00 213.49 (149) .99 .04 (.03-.06)
Group 2 (56-65) .17 .17
Group 3 (≥ 66) .27 .16
Tumor site
Breast (fi xed) .00 224.61 (149) .99 .052 (.03-.06)
Colon -.32 .21
Others -.20 .21
Note: se= standard error; CFI= Comparative Fit Index; RMSEA= Root Mean Square 
Error of Approximation; CI= Confi dent Interval 
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exchangeability discussed above. Some non-linearity appears in 
the upper right corner of the graphic, which evidences the ceiling 
effects due to the asymmetrical item and total score distributions. 
Finally, fi gure 3 shows the curve of the conditional reliability 
of the factor score estimates as a function of trait level. Clearly, 
the PDRQ-9 scores highly provide accuracy at low to medium 
trait levels and decreases abruptly from this level on. In terms 
of sum scores, accuracy will be very high for scores between 0 
and about 40. This profi le would be advantageous if the aim is to 
detect or measure precisely those patients that express low levels 
of satisfaction in the patient-doctor relationship.
Convergent validity evidence 
Validity results in Table 4 can be summarized as follows. First, 
the extended structural validity model yields an acceptable fi t 
with the data. Second, both empirical and model-based validity 
estimates are remarkably similar. This result is expected, given the 
appropriateness of the model and high reliability of the raw PDRQ-9 
scores. As for substantive results, PDRQ-9 correlates negatively 
with Depression and Anxiety (BSI scales) and Functioning scale, 
symptom scale, and global QoL scale (EORTC QLQ-C30 scales). 
Overall, therefore, the most unfavorable patient perception of the 
patient-doctor relationship is associated with all BSI and EORTC 
QLQ-C30 scales, but particularly with worse Quality of Life.
Normative Table 
In order to help the applied psychologist to interpret the responses 
obtained in a practical situation, we constructed a normative table 
to convert raw scores to T-scores and centiles (table 5).
Figure 3. Curve of the conditional reliability of the factor score estimates as a function of trait level
Table 4
Validity Assessment
(a) Empirical and model-based validity relations between the PDQR-9 and external scale 
scores
Scale scores Empirical Model-based
Depression -.12** -.15**
Anxiety                      -.11** -.01**
Functioning -.17**            -.15**
Symptoms -.14** -.15**
Global QOL -.19** -.21**
(b)  Goodness-of-fi t results for the structural validity model
χ 2 (df) CFI RMSEA (90% CI)
539.62 (190) 097 .04 (.04; .05)
Note: CFI= Comparative Fit Index; RMSEA= Root Mean Square Error of Approximation; 
CI= Confi dent Interval
* p<.01; ** p<.001
Table 5
Scale table to convert raw scores to T-scores and centiles
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Discussion
The objective of this study was to evaluate certain psychometric 
properties of the PDRQ-9, a useful instrument to quantify patient 
satisfaction with their relationship with their oncologist. This 
study has confi rmed the one-dimensional structure of the PDRQ-9 
in a sample of adults with non-metastatic, resected cancer. The 
scale exhibits high internal consistency, a well-defi ned, strong 
unifactorial structure, and achieves strong invariance in terms of 
gender, age, and tumor localization. 
Participants’ satisfaction with their oncologist was high 
(M=42), higher than the German (M= 37) (Zenger et al., 2014) 
and Spanish (M=40) (Martín-Fernández et al., 2010) samples. 
This high scoring implies a ceiling effect (Van der Feltz-Cornelis 
et al., 2004; Zenger et al., 2014). Our results show in detail that 
the PDRQ-9 scores measure quite accurately at low to medium 
trait levels but are unable to discriminate well between subjects 
with high satisfaction. The ceiling effect is very common in 
this kind of instrument (Eveleigh et al., 2012), and might partly 
refl ect socially desirable responding (Van der Feltz-Cornelis et 
al., 2004) an issue that requires further research. For the moment, 
however, and substantively the result is especially satisfactory in 
or study, bearing in mind that the patients were under the care of 
an oncologist in a specialized setting. In contrast, Van der Felliz-
Cornelis et al.’s fi ndings that point toward worse satisfaction in 
specialized compared to primary care (Van der Feltz-Cornelis et 
al., 2004). Likewise, the PDRQ-9’s ability to detect those patients 
with low levels of satisfaction in the doctor-patient relationship, 
allows it to make subtle discriminations between the doctor-patient 
relationships established by the faculty doctor (that is, an expert 
in communication) and well-meaning residents (Porcerelli et al., 
2014).
As for the characteristics that are associated with greater 
satisfaction with the patient-doctor relationship, our study revealed 
that men and individuals who are married or partnered are more 
satisfi ed with their oncologist. In general, marital status and gender 
have been linked to cancer patients’ positive perception of the care 
received (Jiménez-Fonseca et al., 2018). Recent reviews have 
reinforced the notion that having a supportive spouse can help with 
the process of adjusting to cancer; spouses can provide external, 
observable, objective information  and complement their partners’ 
perspective that is more internal, personal, and subjective when 
facing their medical situation (Eveleigh et al., 2012; Kayser et al., 
2018).
The high internal consistency detected in this study is similar 
to that found in other populations, such as the Dutch (α=.94) 
(Van der Feltz-Cornelis et al., 2004), German (α=.95) (Zenger 
et al., 2014), Spanish (α=.95) (López, 2009), American (α=.96) 
(Porcerelli et al., 2014), and Turkish (α=.91) (Mergen et al., 
2012). Likewise, there is no item that when eliminated, increases 
the scale’s consistency. Nonetheless, item 2, “My oncologist has 
enough time for me” presents less saturation and the classical item 
discrimination is the lowest. Time is one of oncology patients’ 
chief complaints; oncologists typically see between 25 and 40 
individuals daily – patients with complex medical situations. This, 
together with the emergencies and unexpected events that arise 
negatively impact the time these physicians have per appointment, 
which is why patients perceive this more negatively than the 
remaining indicators. The confi rmatory factor analysis would 
confi rm the questionnaire’s unifactorial structure also found in 
other research (Arafat, 2016; López, 2009; Martín-Fernández et 
al., 2010; Van der Feltz-Cornelis et al., 2004; Zenger et al., 2014) 
with a high amount of common variance. It must be pointed out 
that PDRQ-9 does not include reverse-worded items which could 
have been useful for controlling for the effects of acquiescence 
(Vigil-Colet et al., 2020). However, the patients with cancer who 
answer PDRQ-9 tend to be highly motivated to participate in the 
assessment process, so ‘a priori acquiescence is not likely to be a 
determinant here. 
No gender differences were observed at the level of factor 
loadings, signaling metric or weak invariance across gender in the 
total sample. This means that the latent variable is related to the 
items in the same way for men and women. In terms of gender, 
Women exhibited low levels of satisfaction with their relationship 
with their physician. In age-defi ned groups, results of the invariance 
study indicated that there is no differential functioning in any of 
PDQR-9 items; consequently, the test’s structure is equivalent 
throughout the life span. As for age, levels of satisfaction with 
physician appear to rise with age. However, the difference between 
the oldest and the youngest age group still does no reach statistical 
signifi cance. Strong invariance was also found with respect to 
tumor site, this being the fi rst study that analyzes invariance on 
the basis of tumor characteristics. No signifi cant differences were 
detected between mean levels of patient satisfaction with their 
relationship with the oncologist across the three groups: colon, 
breast, and others.
The PDRQ-9 scores also showed evidence of convergent 
validity, with moderate correlations with the BSI and EORTC QLQ-
C30 scales. The most anxious and/ or depressed subjects exhibited 
less satisfaction with the patient-doctor relationship. This suggests 
that the PDRQ-9 is capable of discriminating between good and 
moderate satisfaction (Van der Feltz-Cornelis et al., 2004). Similar 
fi ndings were encountered in cardiac (Schenker et al., 2009) and 
oncology patients (Porcerelli et al., 2015). Associations were also 
found with quality-of-life indicators (functional status, symptoms, 
and Global QoL), slightly higher than on the emotional component. 
Many health studies have used the PDQR-9 as an indicator of good 
therapeutic alliance among people undergoing medical procedures 
and/ or therapies (Zenger et al., 2014). A good patient-physician 
relationship has been correlated with better treatment compliance, 
greater patient satisfaction, and better prognosis (Pedersen et al., 
2019; Rogers et al., 2019).
There are several limitations to this study. First, our sample 
consisted of individuals with a heterogeneous, localized 
tumor who had undergone surgery. Thus, the results cannot be 
generalized to patients with advanced tumors or cancer survivors. 
Second, the application of the questionnaire in the health context 
can lead to socially acceptable answers and overestimate patients’ 
judgment towards their oncologist. Third, all the patients eligible 
to participate did so voluntarily, which may have introduced a 
self-selection bias. Finally, we administered the questionnaire at a 
specifi c point in time; we do not have data as to how satisfaction 
with the patient-doctor relationship evolves over time. Future 
studies should include follow-up evaluations.
In conclusion, the PDRQ-9 adapted to the context of oncology 
has proven to be a valid, consistent, and convenient instrument 
that makes it possible to use to appraise patients’ opinions of their 
patient-doctor relationship and can be helpful in both clinical care, 
as well as research. This study can help oncologists and hospitals 
assess patients’ quality of care.
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